false
ar,be,bn,zh-CN,zh-TW,en,fr,de,hi,it,ja,ko,pt,ru,es,sw,vi
Catalog
Interactive Updates on Selected Topics in Gynecolo ...
Presentation Recording - Portuguese
Presentation Recording - Portuguese
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The video discusses the need for new treatment options for endometrial cancer, particularly in metastatic or recurrent cases. It highlights various options including inhibitors, hormonal therapy, and anti-HER2 therapies. The promising role of immunotherapy in patients with microsatellite instability is also discussed, along with the use of biomarkers to identify suitable candidates for immunotherapy. The video concludes by stressing the need for more research and investment in the treatment of endometrial cancer.<br /><br />In the webinar, experts cover multiple aspects of endometrial cancer treatment. They focus on systemic treatment advancements, particularly the effectiveness of immunotherapy. The importance of molecular knowledge in guiding treatment decisions is emphasized. Hormonal therapy as a first-line treatment and its combination with platinum-related agents are also discussed. The webinar also delves into the use of the sentinel lymph node technique in surgical approaches, highlighting its significance in staging and treatment planning. Technical details such as uterine manipulators and precise dissection and biopsy techniques are addressed. Overall, the webinar provides valuable insights into the latest treatment advancements and the significance of precise surgical techniques in endometrial cancer management.
Keywords
endometrial cancer
treatment options
metastatic
recurrent cases
inhibitors
hormonal therapy
anti-HER2 therapies
immunotherapy
microsatellite instability
biomarkers
research
investment
systemic treatment advancements
molecular knowledge
surgical approaches
Contact
education@igcs.org
for assistance.
×